[1. POCHA C, KOLLY P, DUFOUR JF. Nonalcoholic fatty liver disease-related hepatocellular carcinoma: A problem of growing magnitude. Semin Liver Dis. 2015; 35(3):304-17.10.1055/s-0035-156294926378646]Search in Google Scholar
[2. FRIEDRICH-RUST M, SCHOELZEL F, MAIER S, SEEGER F, REY J, FICHTLSCHERER S, et al. Severity of coronary artery disease is associated with non-alcoholic fatty liver disease: A single-blinded prospective mono-center study. PLoS One. 2017; 12(10):e0186720.10.1371/journal.pone.0186720565807629073252]Search in Google Scholar
[3. PERERA N, INDRAKUMAR J, ABEYSINGHE WV, FERNANDO V, SAMARAWEERA WM, LAWRENCE JS. Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: An observational study from Sri Lanka. BMC Cardiovasc Disord. 2016;16:37.10.1186/s12872-016-0212-8475170126869052]Search in Google Scholar
[4. GAUDIO E, NOBILI V, FRANCHITTO A, ONORI P, CARPINO G. Nonalcoholic fatty liver disease and atherosclerosis. Intern Emerg Med. 2012; 7 Suppl 3:S297-305.10.1007/s11739-012-0826-523073871]Search in Google Scholar
[5. BONCI E, CHIESA C, VERSACCI P, ANANIA C, SILVESTRI L, PACIFICO L. Association of nonalcoholic fatty liver disease with subclinical cardiovascular changes: A systematic review and meta-analysis. Biomed Res Int. 2015; 2015:213737.10.1155/2015/213737452989926273598]Search in Google Scholar
[6. PARK HE, KWAK MS, KIM D, KIM MK, CHA MJ, CHOI SY. Nonalcoholic fatty liver disease is associated with coronary artery calcification development: A longitudinal study. J Clin Endocrinol Metab. 2016; 101(8):3134-43.10.1210/jc.2016-152527253666]Search in Google Scholar
[7. LI XL, SUI JQ, LU LL, ZHANG NN, XU X, DONG QY, et al. Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: A concise review. Lipids Health Dis. 2016; 15:53.10.1186/s12944-016-0221-8478561626965314]Search in Google Scholar
[8. NSEIR W, SHALATA A, MARMOR A, ASSY N. Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Dig Dis Sci. 2011; 56(12):3439-49.10.1007/s10620-011-1767-y21655948]Search in Google Scholar
[9. ADAMS LA, ANSTEE QM, TILG H, TARGHER G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017; 66(6):1138-53.10.1136/gutjnl-2017-31388428314735]Search in Google Scholar
[10. WANG P-W, HSIEH C-J, PSANG L-C, CHENG Y-F, LIOU C-W, WENG S-W, et al. Fatty liver and chronic inflammation in Chinese adults. Diabetes Research and Clinical Practice. 2008; 81(2):202-08.10.1016/j.diabres.2008.04.01418534708]Search in Google Scholar
[11. PASARIN M, ABRALDES JG, LIGUORI E, KOK B, LA MURA V. Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction. World J Gastroenterol. 2017; 23(37):6777-87.10.3748/wjg.v23.i37.6777564561229085222]Search in Google Scholar
[12. KLISIC A, ISAKOVIC A, KOCIC G, KAVARIC N, JOVANOVIC M, ZVRKO E, et al. Relationship between oxidative stress, inflammation and dyslipidemia with fatty liver index in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2017.10.1055/s-0043-11866728895641]Search in Google Scholar
[13. KIM J, LEE DY, PARK SE, PARK CY, LEE WY, OH KW, et al. Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation. PLoS One. 2017; 12(7):e0180118.10.1371/journal.pone.0180118550145928686633]Search in Google Scholar
[14. KOROGLU E, CANBAKAN B, ATAY K, HATEMI I, TUNCER M, DOBRUCALI A, et al. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease. Turk J Gastroenterol. 2016; 27(4):361-6.10.5152/tjg.2016.1610627458852]Search in Google Scholar
[15. EMRE A, TERZI S, CELIKER E, SAHIN S, YAZICI S, ERDEM A, et al. Impact of nonalcoholic fatty liver disease on myocardial perfusion in nondiabetic patients undergoing primary percutaneous coronary intervention for ST - segment elevation myocardial infarction. The American Journal of Cardiology. 2015; 116(12):1810-4.10.1016/j.amjcard.2015.09.02126506122]Search in Google Scholar
[16. WANG Y, LI YY, NIE YQ, ZHOU YJ, CAO CY, XU L. Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. Experimental and Therapeutic Medicine. 2013; 6(1):77-84.10.3892/etm.2013.1090373556823935723]Search in Google Scholar
[17. NADERIAN M, KOLAHDOOZAN S, SHARIFI AS, GARMAROUDI G, YASERI M, POUSTCHI H, et al. Assessment of lean patients with non-alcoholic fatty liver disease in a middle income country; Prevalence and its association with metabolic disorders: A cross-sectional study. Archives of Iranian Medicine. 2017; 20(4):211-17.]Search in Google Scholar
[18. WU R, HOU F, WANG X, ZHOU Y, SUN K, WANG Y, et al. Nonalcoholic fatty liver disease and coronary artery calcification in a northern Chinese population: A cross sectional study. Sci Rep. 2017; 7(1):9933.10.1038/s41598-017-09851-5557729228855585]Search in Google Scholar
[19. BAHARVAND-AHMADI B, SHARIFI K, NAMDARI M. Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease. ARYA Atheroscler. 2016; 12(4):201-05.]Search in Google Scholar
[20. SUN L, LU SZ. Association between non-alcoholic fatty liver disease and coronary artery disease severity. Chin Med J (Engl). 2011; 124(6):867-72.]Search in Google Scholar
[21. CHOI DH, LEE SJ, KANG CD, PARK MO, CHOI DW, KIM TS, et al. Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans. World J Gastroenterol. 2013; 19(38):6453-7.10.3748/wjg.v19.i38.6453380131624151364]Search in Google Scholar
[22. ARSLAN U, TURKOGLU S, BALCIOGLU S, TAVIL Y, KARAKAN T, CENGEL A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis. 2007; 18(6):433-6.10.1097/MCA.0b013e3282583c0d17700213]Search in Google Scholar